FP6Staff exchange2006–2010

MEMPROT · The technologies of biological membranes

FP6 — Marie Curie Actions (Human Resources and Mobility)

Duration
2006-12-01 → 2010-11-30
EU contribution
€1,066,890
Participants
1
Scheme
TOK

Lines connect the coordinator with its partners.

Results in brief

Final Activity Report Summary - MEMPROT (The Technologies of Biological Membranes)

This project was concerned with the establishment of a laboratory for the study of membrane proteins, a highly topical area of research which is particularly relevant to developing regions within the EU because it offers translational opportunities to the private sector viz. in the area of drug discovery, an activity which the Irish State is keen to encourage. The project was supported by a special University subvention which allowed the infrastructure of the laboratory to be established. The research strategy adopted was to develop membrane-related aspects of topics already under study in the University, coupled with the importation of new areas of research which had potential in the drug discovery area. Thus, research projects were conducted on G-protein coupled receptors (GPCRs) in the field of inflammation and immunity where new expression of both receptor and ligand were achieved. Such receptors command nearly a third of research investment in modern pharma. The very challenging barrier of eukaryotic protein expression was successfully tackled whereby tobacco plants were transformed with vectors containing a GPCR and a ligand-binding domain and seen to express protein. Again, heat shock proteins (yeast disaggregases) were shown to enhance the yield of soluble expressed mammalian proteins in E.coli. All these open up new prospects for circumventing this difficult barrier. The structure and function of a newly identified receptor, that for retinol binding protein, was initiated. A key domain of the protein was expressed and demonstrated to retain native functionality. This allowed a screening assay to be developed which in turn led to the discovery of two series of compounds which were shown to prevent the development of insulin resistance and type 2 diabetes in mice. These are now the subject of some interest by the private Pharmaceutical sector. A yeast-2-hybrid system for use with membrane proteins in order to identifying interacting components with signal tranduction potential was established and used to screen for interactors with this receptor. Finally, a difficult domain, mutations in which are responsible for some forms of retinitis pigmentosa was expressed and the mutations responsible shown to cause aggregation resulting in loss of function and consequent disease. An advanced course on the structure and function of membrane proteins was conducted and undergraduate research projects were designed and supervised by the Marie Curie Fellows. Following its inception, the Laboratory has attracted additional and new funding from a variety of sources as well as independent research Fellows which will ensure that the work initiated will continue and develop. The University has made an appointment in the area to ensure that the Laboratory has a long-term future as an established research unit. Thus, the objective of establishing membrane protein research at NUIM has been amply fulfilled.

Data: CORDIS, © European Union

Project objective

Many will argue that this will be the decade which unlocks the power of the biological membrane. It is the key element in the organisation and regulation of cells and therefore is of fundamental importance to biology. Allied to this, the ability to influence membrane behaviour (eg. by therapeutic intervention) or to harness the principles and components of membranes to technological applications (eg. biosensors) will usher in a new era of exploitation and innovative commercial development. This application is submitted in order to introduce into a rapidly emergent University in Ireland, a range of projects and their accompanying technologies associated with biological membrane science. It will at the same time bring to the whole of Ireland a major research unit dedicated to the study of biomembranes, a field which is under-represented in the Irish research portfolio. In so doing, it will inform and stimulate the community, provide a new focus for research and, most importantly, create a new skills base. This latter aspect is particularly relevant to the development of the private health sector where the greatest proportion of research invested is currently directed towards the membrane. The protein systems to be studied are involved in cellular regulation (eg. G-protein coupled receptors, ion channels, lipocalin receptors) and membrane protein interactions and structure, many associated with defined diseases or human dysfunction. The areas of research will be structure/function relationships, protein interactions, protein folding and assembly, structural characterisation and cell biology. The technologies to be employed include membrane protein expression, purification and reconstitution, membrane-directed 2-hybrid syste4ms, surface plasmon resonance, microphysiometry and the proteomics of membrane systems.

Original text from CORDIS.

Participants

  • National University of Ireland - Maynooth · MAYNOOTHCoordinatorIreland

Links

Data: CORDIS, © European Union